PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to close the Design-Make-Test cycle of medicinal chemistry and bring more cures to patients.
Medicinal Chemistry as a Service, powered by Machine Learning
PostEra is a biotechnology company backed by YCombinator (YC W20).
Drug discovery R&D is slow and expensive and this limits biotechs and pharma from getting new drugs into development and new cures to patients. PostEra is building a one-stop-shop for medicinal chemistry, powered by machine learning, to serve the world's ever expanding community of drug hunters while also leading the world's largest open-science initiative to find a COVID cure; COVID Moonshot.
PostEra offers 2 products:
1. Partnerships - We offer our full stack of machine learning tools to help our partners (small biotech to large pharma) develop drugs faster and cheaper.
2. Manifold - We offer a cloud based platform where drug hunters can use our ML tools to reduce the time and cost of their drug discovery.
As a company we have a particular of focus on chemical synthesis; the process of making molecules and Manifold's flagship product centers on solving this problem of how to get compounds made.
